Jiang Wuhua, Shen Bo, Wang Yimei, Xu Jiarui, Luo Zhe, Ding Xiaoqiang, Teng Jie
Department of Nephrology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Shanghai Institute of Kidney and Dialysis, Shanghai, China.
Braz J Cardiovasc Surg. 2019 Jan-Feb;34(1):33-40. doi: 10.21470/1678-9741-2018-0206.
To discover potentially modifiable perioperative predictors for renal replacement therapy (RRT) in patients with cardiac surgery-associated acute kidney injury (CSA-AKI).
A cohort of 1773 consecutive cardiac surgery patients with postoperative acute kidney injury (AKI) from January 2013 to December 2015 were included retrospectively. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. The primary outcome was CSA-AKI requiring renal replacement therapy (AKI-RRT). The initiation of RRT was based on clinical judgment regarding severe volume overload, metabolic abnormality (e.g., acidosis, hyperkalemia), and oliguria. Patients with AKI-RRT were matched 1:1 with patients without AKI-RRT by a propensity score, to exclude the influence of patients' demographics, comorbidities, and baseline renal function. Multivariable regression was performed to identify the predictors in the matched sample.
AKI-RRT occurred in 4.4% of the entire cohort (n=78/1773), with 28.2% of in-hospital mortality (n=22/78). With the propensity score, 78 pairs of patients were matched 1:1 and the variables found to be predictors of AKI-RRT included the contrast exposure within 3 days before surgery (odds ratio [OR]=2.932), central venous pressure (CVP) >10 mmHg on intensive care unit (ICU) admission (OR=1.646 per mmHg increase), and erythrocyte transfusions on the 1st day of surgery (OR=1.742 per unit increase).
AKI-RRT is associated with high mortality. The potentially modifiable predictors found in this study require concern and interventions to prevent CSA-AKI patients from worsening prognosis.
探寻心脏手术相关急性肾损伤(CSA - AKI)患者围手术期可能可改变的肾脏替代治疗(RRT)预测因素。
回顾性纳入2013年1月至2015年12月连续接受心脏手术且术后发生急性肾损伤(AKI)的1773例患者。AKI根据改善全球肾脏病预后组织(KDIGO)标准定义。主要结局为需要肾脏替代治疗的CSA - AKI(AKI - RRT)。RRT的启动基于对严重容量超负荷、代谢异常(如酸中毒、高钾血症)和少尿的临床判断。通过倾向评分将AKI - RRT患者与非AKI - RRT患者按1:1匹配,以排除患者人口统计学、合并症和基线肾功能的影响。在匹配样本中进行多变量回归以识别预测因素。
整个队列中4.4%(n = 78/1773)发生AKI - RRT,住院死亡率为28.2%(n = 22/78)。通过倾向评分,78对患者按1:1匹配,发现AKI - RRT的预测因素包括术前3天内的造影剂暴露(比值比[OR]=2.932)、重症监护病房(ICU)入院时中心静脉压(CVP)>10 mmHg(每增加1 mmHg,OR = 1.646)以及手术第1天的红细胞输注(每增加1单位,OR = 1.742)。
AKI - RRT与高死亡率相关。本研究中发现的潜在可改变预测因素值得关注并进行干预,以防止CSA - AKI患者预后恶化。